Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2025-12-24 @ 6:25 PM
NCT ID:
NCT00753168
Eligibility Criteria:
Inclusion Criteria:
* healthy subjects, 18 to 80 years of age, any gender
* diagnosis of primary open angle, pseudoexfoliative or pigmentary glaucoma or ocular hypertension
Exclusion Criteria:
* have VA worse than 20/200,
* cataract that compromises visualization of fundus,
* history of lack of response to ocular beta blocker therapy,
* uncontrolled intraocular pressure,
* angle closure glaucoma or occludable angles,
* retinal detachment, macular hole, progressive vision loss, any progressive retinal disease or neurologic disease other than glaucoma that is likely to worsen visual field or acuity during the course of the study,
* a history of, or any current condition contraindicated with use of a beta blocker (e.g., chronic obstructive pulmonary disease, bronchial asthma, congestive heart failure, myasthenia gravis, hypoglycemia, bradycardia, etc),
* chronic use of steroids,
* any disease that, in the opinion of the investigator, may put the patient at significant risk,
* taking systemic beta blockers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00753168
Study Brief:
Protocol Section:
NCT00753168